Columbus A/S
23.2.2026 08:33:17 CET | Globenewswire | Press release
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 9/2026
Transactions in the period 16 February to 20 February 2026
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 16 February to 20 February 2026:
| Number of shares bought | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, last announcement | 1,433,897 | 10.00 | 14,338,328.48 |
| 16 February 2026 | 9,000 | 9.90 | 89,100.00 |
| 17 February 2026 | 9,000 | 9.98 | 89,820.00 |
| 18 February 2026 | 9,000 | 9.90 | 89,080.20 |
| 19 February 2026 | 9,000 | 9.86 | 88,740.00 |
| 20 February 2026 | 9,000 | 9.85 | 88,678.80 |
| Total, 16 February to 20 February 2026 | 45,000 | 9.90 | 445,419.00 |
| Total accumulated under the programme | 1,478,897 | 10.00 | 14,783,747.48 |
With the transactions stated above, Columbus A/S holds a total of 1,478,897 own shares, corresponding to 1.14% of the Company’s share capital.
For further information, please contact: CFO, Brian Iversen, +45 70 20 50 00 |
Attachments
- SE_09_2026_Weekly_report_on_share_buyback
- Columbus - Share buyback transactions 16 February 2026 to 20 February 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S23.2.2026 10:33:03 CET | Press release
Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved
MT Højgaard Holding A/S23.2.2026 10:08:27 CET | Pressemeddelelse
MT Højgaard Holding A/S: Indkaldelse til ordinær generalforsamling 2026
MT Højgaard Holding A/S23.2.2026 10:08:27 CET | Press release
MT Højgaard Holding A/S: Notice of Annual General Meeting 2026
Tryg A/S23.2.2026 10:06:14 CET | Press release
Tryg - Transactions in connection with share buyback programme
Djurslands Bank A/S23.2.2026 10:02:31 CET | Pressemeddelelse
Aktietilbagekøb i Djurslands Bank – transaktioner i uge 8
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom